Palbociclib extends progression-free survival in advanced breast cancer patients

[News]

Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer patients, including those whose disease has stopped responding to traditional endocrine treatments.

More...

[donocco]

I read some info on Palbociclib (Ibrance) and condensded the common side effects with a "nonsense word."

Fanthappal-epi-UTI

Fatigue, anemia, neutropenia, throbocytopenia (Fanth)

appetite decrease, alopecia (usually not severe) = appal

epistaxis (nosebleed) and Upper respiratory infections =Epi-UTI

Perhaps this might be useful

Paul